首页 产品目录 分子砌块 按官能团 羧酸类 (4R)-4-((3R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

(4R)-4-((3R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

(4R)-4-((3R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
25g 95% 询价
- +
100g 95% 询价
- +
500g 95% 询价
- +
1kg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

83-49-8

英文名称

(4R)-4-((3R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

别名

7-deoxyhyocholicacid;alpha-hyodeoxycholicacid;3α,6α-Dihydroxy-5β-cholanoic acid;Hyodeoxycholic;3à,6à-dihydroxy-5á-cholan-24-oic acid;3a,6a-Dihydroxy-5b-Cholan-24-Oic Acid;HYODEOXYCHOLIC ACID FREE ACID;HYODEOXYCHOLIC ACID 98%

标准英文名

(4R)-4-((3R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

分子式

C24H40O4

分子量

392.58

精确分子量

392.29

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)C4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

标准SMILES

C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)C4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C

用途

Hyodeoxycholic acid (HDCA) is used for its hypolipidemic, antispasmodic, and expectorant effects. It is clinically applied in the treatment of hyperlipidemia (types Ia and Ib), atherosclerosis, bronchitis, pediatric viral upper respiratory tract infections, and digestive disorders caused by hepatobiliary diseases. It also exhibits antibacterial activity against Bordetella pertussis, Corynebacterium diphtheriae, and Staphylococcus aureus. As an active ingredient in Qingkailing injection, HDCA has shown efficacy in the treatment of acute leukemia, with in vitro studies demonstrating its ability to induce apoptosis and inhibit cell proliferation. Additionally, it is used in the management of cholangitis, cholecystitis, cholelithiasis, and other non-obstructive cholestasis conditions, and can accelerate the hepatic clearance of cholecystographic agents to enhance imaging. HDCA promotes intestinal fat digestion and absorption of fat-soluble vitamins, and is employed as an anti-inflammatory agent for chronic bronchitis and pediatric viral respiratory infections.

InChIKey

DGABKXLVXPYZII-CDONHWFASA-N

安全信息

SureRoute逆合成路线

1.  83-49-8 逆合成路线 1

—
—
ACQWSK991
83-49-8
来源: SureRoute

2.  83-49-8 逆合成路线 2

—
—
ACQWSK991
83-49-8
来源: SureRoute

3.  83-49-8 逆合成路线 3

—
—
ACQWSK991
83-49-8
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手